Pat Mallon, Chief Operating Officer
Patrick J. Mallon has over 20 years of senior and C-level executive experience in the Life Sciences, Pharmaceutical and Medical Device industries. Mr. Mallon has served a number of private and public companies, both start-up and large, including Genpathway, Genicon Sciences (now Life Technologies), Agouron Pharmaceuticals (now Pfizer), Roche, and Gen-Probe. Mr. Mallon’s expertise includes commercial strategy and implementation, operational management, product development, portfolio management, licensing and M&A as well as company formation and financing. Mr. Mallon has led and/or participated in structuring numerous financial transactions including the raising of over $50 million in private equity greater than $500 million in strategic partnerships and/or licenses and over $5 billion in M&A transactions. Additionally, Mr. Mallon has been integral in the development and commercialization of a number of new technologies and drugs including PCR technology, protease inhibitors for HIV, biomarker/companion diagnostics, and more recently wireless health-related (mHealth) technology.
Andrew Buckland, Chief Financial Officer
Andrew Buckland has extensive experience in the development of financial operations within both large multinational corporations and early to mid-stage companies. He has a diverse background in international business as well as over ten years as the most senior financial officer of U.S. public and pre-IPO life sciences companies. Most recently, Mr. Buckland served as Chief Financial Officer of PURE Bioscience, Inc., a company he took from the OTC Bulletin Board to the NASDAQ Stock Market. Prior to PURE Bioscience, Mr. Buckland served as Vice President of Finance at Cardionet, Inc., as Chief Financial Officer of Advanced Tissue Sciences, Inc., a NASDAQ-listed public biotechnology company, and in significant international accounting and financial management positions at Bristol-Myers Squibb and United Parcel Service. He has completed several private placements and registered direct common stock offerings in the United States, and obtained SEC effectiveness on multiple registration statements. Mr. Buckland earned an MBA from the University of California, Irvine and a BA (with Honors) from the University of the West of England.